» Articles » PMID: 29925420

Hepatic Steatosis Risk is Partly Driven by Increased De Novo Lipogenesis Following Carbohydrate Consumption

Abstract

Background: Diet is a major contributor to metabolic disease risk, but there is controversy as to whether increased incidences of diseases such as non-alcoholic fatty liver disease arise from consumption of saturated fats or free sugars. Here, we investigate whether a sub-set of triacylglycerols (TAGs) were associated with hepatic steatosis and whether they arise from de novo lipogenesis (DNL) from the consumption of carbohydrates.

Results: We conduct direct infusion mass spectrometry of lipids in plasma to study the association between specific TAGs and hepatic steatosis assessed by ultrasound and fatty liver index in volunteers from the UK-based Fenland Study and evaluate clustering of TAGs in the National Survey of Health and Development UK cohort. We find that TAGs containing saturated and monounsaturated fatty acids with 16-18 carbons are specifically associated with hepatic steatosis. These TAGs are additionally associated with higher consumption of carbohydrate and saturated fat, hepatic steatosis, and variations in the gene for protein phosphatase 1, regulatory subunit 3b (PPP1R3B), which in part regulates glycogen synthesis. DNL is measured in hyperphagic ob/ob mice, mice on a western diet (high in fat and free sugar) and in healthy humans using stable isotope techniques following high carbohydrate meals, demonstrating the rate of DNL correlates with increased synthesis of this cluster of TAGs. Furthermore, these TAGs are increased in plasma from patients with biopsy-confirmed steatosis.

Conclusion: A subset of TAGs is associated with hepatic steatosis, even when correcting for common confounding factors. We suggest that hepatic steatosis risk in western populations is in part driven by increased DNL following carbohydrate rich meals in addition to the consumption of saturated fat.

Citing Articles

Dietary fat quantity and composition influence hepatic lipid metabolism and metabolic disease risk in humans.

Srnic N, Westcott F, Caney E, Hodson L Dis Model Mech. 2025; 18(1).

PMID: 39878508 PMC: 11810042. DOI: 10.1242/dmm.050878.


Diverting hepatic lipid fluxes with lifestyles revision and pharmacological interventions as a strategy to tackle steatotic liver disease (SLD) and hepatocellular carcinoma (HCC).

Misceo D, Mocciaro G, DAmore S, Vacca M Nutr Metab (Lond). 2024; 21(1):112.

PMID: 39716321 PMC: 11668039. DOI: 10.1186/s12986-024-00871-3.


Association Between Percent Body Fat Reduction and Changes of the Metabolic Score for Insulin Resistance in Overweight/Obese People with Metabolic Dysfunction-Associated Steatotic Liver Disease.

Han Y, Liu J, Li W, Zhang F, Mao Y Diabetes Metab Syndr Obes. 2024; 17:4735-4747.

PMID: 39678229 PMC: 11646437. DOI: 10.2147/DMSO.S486841.


Lipid metabolism in MASLD and MASH: From mechanism to the clinic.

Carli F, Della Pepa G, Sabatini S, Vidal Puig A, Gastaldelli A JHEP Rep. 2024; 6(12):101185.

PMID: 39583092 PMC: 11582433. DOI: 10.1016/j.jhepr.2024.101185.


Systemic analysis shows that cold exposure modulates triglyceride accumulation and phospholipid distribution in mice.

James I, Jain R, Wade G, Stevenson P, Koulman A, Simcox J PLoS One. 2024; 19(11):e0313205.

PMID: 39509438 PMC: 11542792. DOI: 10.1371/journal.pone.0313205.


References
1.
Conlon B, Beasley J, Aebersold K, Jhangiani S, Wylie-Rosett J . Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD). Nutrients. 2013; 5(10):4093-114. PMC: 3820061. DOI: 10.3390/nu5104093. View

2.
Chan S, Sun R, Zeng X, Choong Z, Wang H, Watt M . Activation of PPARα ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress. Diabetes. 2013; 62(6):2095-105. PMC: 3661626. DOI: 10.2337/db12-1397. View

3.
Semple R, Sleigh A, Murgatroyd P, Adams C, Bluck L, Jackson S . Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. J Clin Invest. 2009; 119(2):315-22. PMC: 2631303. DOI: 10.1172/JCI37432. View

4.
Felix D, Costenaro F, Gottschall C, Coral G . Non-alcoholic fatty liver disease (Nafld) in obese children- effect of refined carbohydrates in diet. BMC Pediatr. 2016; 16(1):187. PMC: 5111335. DOI: 10.1186/s12887-016-0726-3. View

5.
Fabbrini E, Magkos F, Mohammed B, Pietka T, Abumrad N, Patterson B . Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A. 2009; 106(36):15430-5. PMC: 2741268. DOI: 10.1073/pnas.0904944106. View